Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microcapsule Traps and Kills Harmful Bacteria

By LabMedica International staff writers
Posted on 11 Dec 2008
American researchers are reporting the development of microscopic particles that act as chemical traps for bacteria. More...
The traps attract and kill up to 95% of nearby bacteria, including microbes responsible for troublesome hospital-based infections. The scientists described their discovery as micro-sized "roach motels” for harmful bacteria.

In the study, Dr. David G. Whitten, from the University of New Mexico (Albuquerque, USA), and Dr. Kirk S. Schanze, from the chemistry department of the University of Florida (Gainesville, USA), working together with a team of faculty and graduate student collaborators, pointed out that bacterial contamination of medical devices causes up to 1.4 million deaths per year. Moreover, bacteria are becoming more resistant to conventional methods of disinfection. Scientists also are increasingly concerned about the possibility of intentional release of harmful bacteria by terrorists. As a result, researchers are attempting to develop new and improved methods of disinfection.

The New Mexico and Florida teams of researchers study involved the development of light-activated, hollow microcapsules composed of an organic conducting polymer. The antibacterial microcapsules can attract, capture, and destroy bacteria. In controlled laboratory tests, the researchers exposed the capsules to either Pseudomonas aeruginosa, one of the deadliest and most common hospital-based pathogens, or Cobetia marina, a type of bacterium that soils the hulls of ships and other marine equipment. After one hour of light exposure, the light-activated capsules killed more than 95% of the exposed bacteria, the researchers reported. The microcapsules can be applied to a variety of surfaces, including medical equipment, they added.

The scientists' study was published online, ahead of print, on November 24, 2008, in the first issue of a new journal, Applied Materials & Interfaces.

Related Links:
University of New Mexico



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.